Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

PD-1/PD-L1 and immunotherapy for pancreatic cancer
Mengyu Feng, Guangbing Xiong, Zhe Cao, et al.
Cancer Letters (2017) Vol. 407, pp. 57-65
Closed Access | Times Cited: 284

Showing 1-25 of 284 citing articles:

Tumor microenvironment participates in metastasis of pancreatic cancer
Bo Ren, Ming Cui, Gang Yang, et al.
Molecular Cancer (2018) Vol. 17, Iss. 1
Open Access | Times Cited: 499
Recent Advances in Hyperthermia Therapy‐Based Synergistic Immunotherapy
Mengyu Chang, Zhiyao Hou, Man Wang, et al.
Advanced Materials (2020) Vol. 33, Iss. 4
Closed Access | Times Cited: 349
Metabolism of pancreatic cancer: paving the way to better anticancer strategies
Qin Cheng, Gang Yang, Jinshou Yang, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 294
Targeting hypoxic tumor microenvironment in pancreatic cancer
Jinxin Tao, Gang Yang, Wenchuan Zhou, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 289
The role of PD-1/PD-L1 and application of immune-checkpoint inhibitors in human cancers
Tang Qing, Yun Chen, Xiaojuan Li, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 276
PD-L1
Anthousa Kythreotou, Abdul Siddique, Francesco Mauri, et al.
Journal of Clinical Pathology (2017) Vol. 71, Iss. 3, pp. 189-194
Open Access | Times Cited: 268
Niraparib activates interferon signaling and potentiates anti-PD-1 antibody efficacy in tumor models
Zebin Wang, Kaiming Sun, Yonghong Xiao, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 205
Current advances and outlooks in immunotherapy for pancreatic ductal adenocarcinoma
Jiaqiao Fan, Mengfei Wang, Hailong Chen, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 169
c-Met and PD-L1 on Circulating Exosomes as Diagnostic and Prognostic Markers for Pancreatic Cancer
Alexander Lux, Christoph Kahlert, Robert Grützmann, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 13, pp. 3305-3305
Open Access | Times Cited: 148
Spatially restricted drivers and transitional cell populations cooperate with the microenvironment in untreated and chemo-resistant pancreatic cancer
Daniel Cui Zhou, Reyka G. Jayasinghe, Siqi Chen, et al.
Nature Genetics (2022) Vol. 54, Iss. 9, pp. 1390-1405
Open Access | Times Cited: 132
The role of lncRNAs and circRNAs in the PD-1/PD-L1 pathway in cancer immunotherapy
Wenxiao Jiang, Shuya Pan, Xin Chen, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 120
Engineered TCR-T Cell Immunotherapy in Anticancer Precision Medicine: Pros and Cons
Qijie Zhao, Yu Jiang, Shixin Xiang, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 115
Tumor microbiome links cellular programs and immunity in pancreatic cancer
Bassel Ghaddar, Antara Biswas, Chris Harris, et al.
Cancer Cell (2022) Vol. 40, Iss. 10, pp. 1240-1253.e5
Open Access | Times Cited: 101
Discovery of Small-Molecule Inhibitors of the PD-1/PD-L1 Axis That Promote PD-L1 Internalization and Degradation
Tianyu Wang, Shi Cai, Yao Cheng, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 5, pp. 3879-3893
Closed Access | Times Cited: 88
Trastuzumab upregulates PD-L1 as a potential mechanism of trastuzumab resistance through engagement of immune effector cells and stimulation of IFNγ secretion
Bharat K. R. Chaganty, Songbo Qiu, Anneliese M. M. Gest, et al.
Cancer Letters (2018) Vol. 430, pp. 47-56
Open Access | Times Cited: 157
The plasticity of pancreatic cancer metabolism in tumor progression and therapeutic resistance
Douglas E. Biancur, Alec C. Kimmelman
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2018) Vol. 1870, Iss. 1, pp. 67-75
Open Access | Times Cited: 122
Prognostic significance of circulating PD-1, PD-L1, pan-BTN3As, BTN3A1 and BTLA in patients with pancreatic adenocarcinoma
Benjamin Bian, Daniele Fanale, Nelson Dusetti, et al.
OncoImmunology (2019) Vol. 8, Iss. 4, pp. e1561120-e1561120
Open Access | Times Cited: 114
TGFβ Blockade Augments PD-1 Inhibition to Promote T-Cell–Mediated Regression of Pancreatic Cancer
Daniel R. Principe, Alex Park, Matthew J. Dorman, et al.
Molecular Cancer Therapeutics (2018) Vol. 18, Iss. 3, pp. 613-620
Open Access | Times Cited: 104
Development of Inhibitors of the Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Signaling Pathway
Tianyu Wang, Xiaoxing Wu, Changying Guo, et al.
Journal of Medicinal Chemistry (2018) Vol. 62, Iss. 4, pp. 1715-1730
Closed Access | Times Cited: 102
Prognostic Impact of Tumor-Infiltrating Lymphocytes and Neutrophils on Survival of Patients with Upfront Resection of Pancreatic Cancer
Rainer Christoph Miksch, Markus B. Schoenberg, Maximilian Weniger, et al.
Cancers (2019) Vol. 11, Iss. 1, pp. 39-39
Open Access | Times Cited: 102
Overexpressed ITGA2 promotes malignant tumor aggression by up-regulating PD-L1 expression through the activation of the STAT3 signaling pathway
Dianyun Ren, Jingyuan Zhao, Yan Sun, et al.
Journal of Experimental & Clinical Cancer Research (2019) Vol. 38, Iss. 1
Open Access | Times Cited: 102
Long noncoding RNA LINC00473 drives the progression of pancreatic cancer via upregulating programmed death‐ligand 1 by sponging microRNA‐195‐5p
Wenyang Zhou, Mingming Zhang, Chang Liu, et al.
Journal of Cellular Physiology (2019) Vol. 234, Iss. 12, pp. 23176-23189
Closed Access | Times Cited: 97
Long-Term Gemcitabine Treatment Reshapes the Pancreatic Tumor Microenvironment and Sensitizes Murine Carcinoma to Combination Immunotherapy
Daniel R. Principe, Matthew Narbutis, Sandeep Kumar, et al.
Cancer Research (2020) Vol. 80, Iss. 15, pp. 3101-3115
Open Access | Times Cited: 97
Overexpressed histone acetyltransferase 1 regulates cancer immunity by increasing programmed death-ligand 1 expression in pancreatic cancer
Ping Fan, Jingyuan Zhao, Zibo Meng, et al.
Journal of Experimental & Clinical Cancer Research (2019) Vol. 38, Iss. 1
Open Access | Times Cited: 82
Tumor-associated macrophages promote PD-L1 expression in tumor cells by regulating PKM2 nuclear translocation in pancreatic ductal adenocarcinoma
Qing Xia, Jing Jia, Chupeng Hu, et al.
Oncogene (2021) Vol. 41, Iss. 6, pp. 865-877
Open Access | Times Cited: 71
Page 1 - Next Page

Scroll to top